2024
Variation in symptoms of common mental disorders in the general population during the COVID-19 pandemic: longitudinal cohort study
Saunders R, Buckman J, Suh J, Fonagy P, Pilling S, Bu F, Fancourt D. Variation in symptoms of common mental disorders in the general population during the COVID-19 pandemic: longitudinal cohort study. BJPsych Open 2024, 10: e45. PMID: 38344903, PMCID: PMC10897705, DOI: 10.1192/bjo.2024.2.Peer-Reviewed Original ResearchClinically significant symptomsSymptoms of depressionMental health servicesMental disordersTrajectory classesClinically significant symptoms of depressionSignificant symptoms of depressionClinically significant symptom levelsSignificant symptomsHigher neuroticism scoresPersonality-related characteristicsGrowth mixture modelingMental health disordersMental health diagnosesNeuroticism scoresSymptom levelsGeneral populationClinical rangeExperience depressionAnxietyHealth disordersCOVID-19 Social StudyDepressionHealth diagnosisHealth services
2014
‘Can you look me in the face?’ Short-term SSRI Administration Reverts Avoidant Ocular Face Exploration in Subjects at Risk for Psychopathology
Di Simplicio M, Doallo S, Costoloni G, Rohenkohl G, Nobre A, Harmer C. ‘Can you look me in the face?’ Short-term SSRI Administration Reverts Avoidant Ocular Face Exploration in Subjects at Risk for Psychopathology. Neuropsychopharmacology 2014, 39: 3059-3066. PMID: 25035080, PMCID: PMC4229577, DOI: 10.1038/npp.2014.159.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalysis of VarianceAntisocial Personality DisorderCitalopramDiscrimination, PsychologicalDouble-Blind MethodEye MovementsFacial ExpressionFemaleHumansMalePersonality InventoryPsychiatric Status Rating ScalesRecognition, PsychologySelective Serotonin Reuptake InhibitorsStatistics as TopicSurveys and QuestionnairesVisual Analog ScaleYoung AdultConceptsFacial stimuliOcular explorationStudy 2Study 1Serotonin reuptake inhibitor citalopramRecognition of positive emotionsReduced eye gazeEysenck Personality QuestionnaireReuptake inhibitor citalopramLow neuroticism scoresNegative facial expressionsEye gaze movementsDouble-blind designHappy facesSSRI administrationFear expressionHigh neuroticismInhibitor citalopramPersonality QuestionnaireNeuroticism scoresEmotional stimuliInterpersonal difficultiesFace stimuliSocial stimuliFace exploration
1998
Serotonin Transporter Protein Gene Polymorphism and Personality Measures in African American and European American Subjects
Gelernter J, Kranzler H, Coccaro EF, Siever LJ, New AS. Serotonin Transporter Protein Gene Polymorphism and Personality Measures in African American and European American Subjects. American Journal Of Psychiatry 1998, 155: 1332-1338. PMID: 9766763, DOI: 10.1176/ajp.155.10.1332.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack PeopleCarrier ProteinsFemaleGene FrequencyGenotypeHumansIntronsMaleMembrane GlycoproteinsMembrane Transport ProteinsNerve Tissue ProteinsPersonalityPersonality DisordersPolymorphism, GeneticPromoter Regions, GeneticSerotoninSerotonin Plasma Membrane Transport ProteinsSubstance-Related DisordersWhite PeopleConceptsOverall negative findingsSLC6A4 promoter polymorphismNormal comparison subjectsPsychiatric diagnostic groupsProtein gene polymorphismsAmerican subjectsSynaptic inactivationComparison subjectsPromoter polymorphismPsychiatric diagnosisEuropean-American subjectsGene polymorphismsNeuroticism scoresDiagnostic groupsDemographic featuresNegative findingsHarm avoidanceNeurotransmitter serotoninSubstance dependenceSerotonin transporterPersonality disorderSLC6A4 polymorphismsDemographic factorsPresent findingsPromoter region
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply